loadpatents
name:-0.027768850326538
name:-0.0042600631713867
name:-0.0030832290649414
Carter; Todd A. Patent Filings

Carter; Todd A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carter; Todd A..The latest application filed is for "neurogenesis by muscarinic receptor modulation".

Company Profile
1.4.21
  • Carter; Todd A. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Neurogenesis By Muscarinic Receptor Modulation
App 20110319386 - Barlow; Carrolee ;   et al.
2011-12-29
Neurogenesis By Modulating Angiotensin
App 20110269717 - BARLOW; Carrolee ;   et al.
2011-11-03
Combinations containing a 4-acylaminopyridine derivative
Grant 7,998,971 - Barlow , et al. August 16, 2
2011-08-16
Modulation of neurogenesis by PDE inhibition
Grant 7,985,756 - Barlow , et al. July 26, 2
2011-07-26
Neurogenesis By Modulating Angiotensin
App 20110092464 - BARLOW; Carolee ;   et al.
2011-04-21
Neurogenesis by modulating angiotensin
Grant 7,858,611 - Barlow , et al. December 28, 2
2010-12-28
Modulation Of Neurogenesis Using D-cycloserine Combinations
App 20100216805 - Barlow; Carrolee ;   et al.
2010-08-26
Modulation Of Neurogenesis By Nootropic Agents
App 20100216734 - Barlow; Carrolee ;   et al.
2010-08-26
Neurogenesis By Muscarinic Receptor Modulation
App 20100120842 - Barlow; Carrolee ;   et al.
2010-05-13
Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
Grant 7,678,363 - Barlow , et al. March 16, 2
2010-03-16
5 Ht Receptor Mediated Neurogenesis
App 20100009983 - Barlow; Carrolee ;   et al.
2010-01-14
Mcc-257 Modulation Of Neurogenesis
App 20090239834 - Barlow; Carrolee ;   et al.
2009-09-24
Aliskiren Modulation Of Neurogenesis
App 20090197823 - Barlow; Carrolee ;   et al.
2009-08-06
Modulation Of Neurogenesis With Use of Modafinil
App 20080171750 - Barlow; Carrolee ;   et al.
2008-07-17
Neurogenesis By Modulating Angiotensin
App 20080167291 - Barlow; Carolee ;   et al.
2008-07-10
Modulation of Neurogenesis By Melatoninergic Agents
App 20080167363 - Barlow; Carrolee ;   et al.
2008-07-10
Melanocortin Receptor Mediated Modulation Of Neurogenesis
App 20080108574 - Barlow; Carrolee ;   et al.
2008-05-08
HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS
App 20080103105 - Barlow; Carrolee ;   et al.
2008-05-01
Ppar Mediated Modulation Of Neurogenesis
App 20080103165 - Barlow; Carrolee ;   et al.
2008-05-01
Combinations Containing A 4-acylaminopyridine Derivative
App 20080064671 - Barlow; Carrolee ;   et al.
2008-03-13
Modulation Of Neurogenesis By Nootropic Agents
App 20070244143 - Barlow; Carrolee ;   et al.
2007-10-18
Modulation Of Neurogenesis By Pde Inhibition
App 20070208029 - Barlow; Carrolee ;   et al.
2007-09-06
Gaba Receptor Mediated Modulation Of Neurogenesis
App 20070112017 - Barlow; Carrolee ;   et al.
2007-05-17
MODULATION OF NEUORGENESIS BY HDac INHIBITION
App 20070078083 - Barlow; Carrolee ;   et al.
2007-04-05
Methods for identifying agents and conditions that modulate neurogenesis
App 20070015138 - Barlow; Carrolee ;   et al.
2007-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed